• 1. Application of HPLC-Q/orbitrap MS in the detection and identification of anticancer constituents in ethyl acetate components from Hedyotis diffusa
  Xi Chen,Baojin Zhao,Mengjiao Zhang,Min Dong,Yunlan Li,Qingshan Li Anal. Methods 2020 12 4037
• 2. Synthesis and cation-mediated electron transfer in intramolecular fluorescence quenching of donor–acceptor podands: observation of Marcus inverted region in forward electron transfer reactions
  Hua Jiang,Huijun Xu,Jianping Ye J. Chem. Soc. Perkin Trans. 2 2000 925
• 3. Photoremovable protecting groups as controlled-release device for sex pheromone
  Sanghamitra Atta,Mohammed Ikbal,Nishitha Boda,Samiran S. Gauri,N. D. Pradeep Singh Photochem. Photobiol. Sci. 2013 12 393
• 4. Rubia tinctorum root extracts: chemical profile and management of type II diabetes mellitus
  Enas E. Eltamany,Mohamed S. Nafie,Dina M. Khodeer,Aya H. H. El-Tanahy,Maged S. Abdel-Kader,Jihan M. Badr,Reda F. A. Abdelhameed RSC Adv. 2020 10 24159
• 5. A simple and smart oxygen sensor based on the intrazeolite reactions of a substituted anthraquinone
  Katherine L. McGilvray,Michelle N. Chrétien,Matthew Lukeman,J. C. Scaiano Chem. Commun. 2006 4401

• Solvents and Organic Chemicals Organic Compounds Benzenoids Anthracenes Anthraquinones
• Anthraquinones

Recent Advances in the Study of 2-(Hydroxymethyl)anthracene-9,10-dione (CAS: 17241-59-7) in Chemical Biology and Pharmaceutical Research

2-(Hydroxymethyl)anthracene-9,10-dione (CAS: 17241-59-7) is a derivative of anthraquinone, a class of compounds known for their diverse biological activities and applications in medicinal chemistry. Recent studies have highlighted its potential as a scaffold for drug development, particularly in the areas of anticancer, antimicrobial, and anti-inflammatory therapies. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, mechanisms of action, and therapeutic applications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the synthetic pathways for 2-(Hydroxymethyl)anthracene-9,10-dione, optimizing conditions to improve yield and purity. The study emphasized the importance of the hydroxymethyl group in enhancing the compound's solubility and bioavailability, which are critical for its pharmacological efficacy. The researchers also conducted in vitro assays to evaluate its cytotoxic effects on various cancer cell lines, revealing promising activity against breast and lung cancer cells.

Another significant development was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where the compound's antimicrobial properties were investigated. The study demonstrated that 2-(Hydroxymethyl)anthracene-9,10-dione exhibits broad-spectrum activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanism of action was attributed to the disruption of bacterial cell membrane integrity and inhibition of key enzymatic processes. These findings suggest its potential as a lead compound for developing new antibiotics.

Further research has explored the anti-inflammatory effects of 2-(Hydroxymethyl)anthracene-9,10-dione. A 2023 study in the European Journal of Pharmacology showed that the compound inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6 in macrophages. This effect was mediated through the modulation of the NF-κB signaling pathway, highlighting its potential as a therapeutic agent for inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease.

In addition to its therapeutic applications, recent studies have also investigated the compound's role in chemical biology. For instance, a 2024 study in Chemical Communications described its use as a fluorescent probe for detecting reactive oxygen species (ROS) in cellular environments. The hydroxymethyl group was found to enhance the probe's sensitivity and selectivity, making it a valuable tool for studying oxidative stress-related diseases.

Despite these advancements, challenges remain in the clinical translation of 2-(Hydroxymethyl)anthracene-9,10-dione. Issues such as pharmacokinetics, toxicity profiles, and formulation stability need to be addressed in future studies. However, the compound's multifaceted biological activities and structural versatility make it a promising candidate for further research and development in the pharmaceutical and chemical biology fields.

In conclusion, recent studies on 2-(Hydroxymethyl)anthracene-9,10-dione (CAS: 17241-59-7) have expanded our understanding of its potential applications in drug discovery and chemical biology. Its anticancer, antimicrobial, and anti-inflammatory properties, coupled with its utility as a molecular probe, underscore its significance in contemporary research. Continued exploration of this compound is expected to yield novel therapeutic agents and tools for biomedical research.

• 117-78-2(Anthraquinone-2-carboxylic acid)
• 13235-08-0(2-Anthracenecarboxylic acid, 9,10-dihydro-9,10-dioxo-, sodium salt (1:1))
• 27485-15-0(2,3-Anthraquinonedicarboxylic Acid)
• 847802-82-8(2,3-Anthracenedicarboxylic acid, 9,10-dihydro-6-methyl-9,10-dioxo-)
• 88544-77-8(Methanone, [(hydroxymethyl)phenyl]phenyl-)
• 869104-57-4(2,3-Anthracenedicarboxylic acid, 9,10-dihydro-5,6,8-trimethyl-9,10-dioxo-)
• 7475-29-8(1,2-Anthracenedicarboxylicacid, 9,10-dihydro-9,10-dioxo-)
• 52839-61-9(2,3,6-Anthracenetricarboxylic acid, 9,10-dihydro-9,10-dioxo-)
• 109039-74-9(1,4,5,8-Anthracenetetracarboxylic acid, 9,10-dihydro-9,10-dioxo-)
• 869705-61-3(2,3-Anthracenedicarboxylic acid, 9,10-dihydro-6,7-dimethyl-9,10-dioxo-)